Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr, last accessed on 23/01/2017.Search in Google Scholar

2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49(6):1374-403.10.1016/j.ejca.2012.12.027Open DOISearch in Google Scholar

3. Richart RM. Cervical intraepithelial neoplasia. Pathol Annu.1973; 8:301-28.Search in Google Scholar

4. Lorincz AT, Reid R, Jensen AB, et al. Human papillomavirus infection of the cervix; Relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992;39(2):152.10.1016/0020-7292(92)90921-5Search in Google Scholar

5. Zuna RE, Wang SS, Schiffman M, et al. Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion. Cancer. 2006; 108(5):288-97. DOI: 10.1002/cncr.22168.10.1002/cncr.22168Open DOISearch in Google Scholar

6. Yim EK, Park JS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat. 2005; 37(6):319-24. DOI: 10.4143/crt.2005.37.6.319.10.4143/crt.2005.37.6.319Open DOISearch in Google Scholar

7. Gewin L, Galloway DA. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J. Virol 2001. 75:7198-201. DOI: 10.1128/JVI.75.15.7198-7201.2001.10.1128/JVI.75.15.7198-7201.2001Open DOISearch in Google Scholar

8. Oh, ST, Kyo S, Laimins LA. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J Virol. 2001; 75:5559-66. DOI: 10.1128/JVI.75.12.5559-5566.2001.10.1128/JVI.75.12.5559-5566.2001Search in Google Scholar

9. Veldman T, Horikawa I, Barrett JC, et al. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol. 2001. 75:4467-72. DOI: 10.1128/JVI.75.9.4467-4472.2001.10.1128/JVI.75.9.4467-4472.2001Open DOISearch in Google Scholar

10. Chen CH, Chen RJ. Prevalence of telomerase activity in human cancer. J Formos Med Assoc. 2011; 110(5):275-89. DOI:10.1016/S0929-6646(11)60043-0.10.1016/S0929-6646(11)60043-0Search in Google Scholar

11. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science. 1995; 269:1236-41. DOI: 10.1126/science.7544491.10.1126/.7544491Open DOISearch in Google Scholar

12. Kilian A, Bowtell DD, Abud HE, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 1997; 6:2011-9.10.1093/hmg/6.12.20119328464Search in Google Scholar

13. Gardano L, Holland L, Oulton R, et al. Native gel electrophoresis of human telomerase distinguishes active complexes with or without dyskerin. Nucleic Acids Res. 2012; 40(5):e36. DOI:10.1093/nar/gkr1243.10.1093/nar/gkr1243Open DOISearch in Google Scholar

14. Collins K. Structure and function of telomerase. Curr Opin Cell Biol. 1996; 8:374–80. DOI: 10.1016/S0955-0674(96)80013-5.10.1016/S0955-0674(96)80013-5Search in Google Scholar

15. Hiyama E, Tatsumoto N, Kodama T, et al. Telomerase activity in human intestine. Int J Oncol. 1996; 9(3): 453-8. DOI: 10.3892/ijo.9.3.453.10.3892/ijo.9.3.453Search in Google Scholar

16. Zhang F, Huber O, Ménard L, et al. Pontin and reptin, two related ATPases with multiple roles in cancer. Cancer Res. 2008; 68(17):6873-6. DOI: 10.1158/0008-5472.CAN-08-0547.10.1158/0008-5472.CAN-08-0547Open DOISearch in Google Scholar

17. Zhang F, Cheng D, Wang S, Zhu J. Human Specific Regulation of the Telomerase Reverse Transcriptase Gene. Genes (Basel). 2016; 7(7). pii: E30. DOI: 10.3390/genes7070030.10.3390/genes7070030Open DOISearch in Google Scholar

18. Yoshida K, Sugino T, Goodison S, et al. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer. 1997; (75) 548-553. DOI:10.1038/bjc.1997.96.10.1038/bjc.1997.96Open DOISearch in Google Scholar

19. Myung SJ, Yang SK, Chang HS, et al. Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients. J Gastroenterol Hepatol. 2005; (20)1578-1583. DOI: 10.1111/j.1440-1746.2005.03877.x.10.1111/j.1440-1746.2005.03877.xOpen DOISearch in Google Scholar

20. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 1997; 90(4):785-95. DOI: http://dx.doi.org/10.1016/S00928674(00)80538-3.10.1016/S00928674(00)80538-3Open DOISearch in Google Scholar

21. Frost M, Bobak JB, Gianani R, et al. Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix. Am J Clin Pathol. 2000; 114(5): 726-34. DOI:10.1309/XWFE-ARMN-HG2D-AJYV.10.1309/XWFE-ARMN-HG2D-AJYV11068546Open DOISearch in Google Scholar

22. Yokoyama Y, Takahashi Y, Shinohara A, et al. Telomerase activity in the female reproductive tract and neoplasms. Gynecol Oncol. 1998; 68:145-9 DOI:10.1006/gyno.1997.4921.10.1006/gyno.1997.49219514809Open DOISearch in Google Scholar

23. Kyo S, Takakura M, Kohama T, et al. Telomerase activity in human endometrium Cancer Res. 1997; 57:610-4.Search in Google Scholar

24. Yokoyama Y, Takahashi Y, Morishita S, et al. Telomerase activity in the human endometrium throughout the menstrual cycle. Mol Hum Reprod. 1998; 4:173-7. DOI: 10.1093/molehr/4.2.173.10.1093/molehr/4.2.1739542976Open DOISearch in Google Scholar

25. Gorham H, Yoshida K, Sugino T, et al. Telomerase activity in human gynecological malignancies. J Clin Pathol. 1997; 50:501-4. DOI: 10.1136/jcp.50.6.501.10.1136/jcp.50.6.5014999879378818Open DOISearch in Google Scholar

26. Brien TP, Kallakury BV, Lowry CV, et al. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res. 1997; 57: 2760-64.Search in Google Scholar

27. Nobre RJ, de Almeida LP, Martins TC. Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm. J Clin Virol. 2008; 42(1):13-21. DOI: 10.1016/j.jcv.2007.11.021.10.1016/j.jcv.2007.11.02118304866Open DOISearch in Google Scholar

28. Saleh S, Lam AK, Ho YH. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology. 2008; 40(1):25-30. DOI: 10.1080/00313020701716425.10.1080/0031302070171642518038311Open DOISearch in Google Scholar

29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402-8. DOI: 10.1006/meth.2001.1262.10.1006/meth.2001.126211846609Search in Google Scholar

30. Branca M, Giorgi C, Ciotti M, et al. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer. Diagn Cytopathol. 2006; 34(11):739-48. DOI: 10.1002/dc.20554.10.1002/dc.2055417041957Open DOISearch in Google Scholar

31. Hsu CG, Wang PH, Ko JL, et al. Concurrent high expression of human telomerase reverse transcriptase and human non metastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix. Int J Gynecol Cancer. 2007;17(4):851-7. DOI:10.1111/j.1525-1438.2007.00894.x.10.1111/j.1525-1438.2007.00894.x17359290Open DOISearch in Google Scholar

32. Wang HY, Park S, Kim S, et al. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors. Am J Clin Pathol. 2015; 143(3):344-51. DOI:10.1309/AJCPF2XGZ2XIQYQX.10.1309/AJCPF2XGZ2XIQYQX25696792Open DOISearch in Google Scholar

33. Saretzki G, Fischer H, Kaufmann IG, et al. Telomerase activity in cervical smears. Anal Cell Pathol. 2001; 23(1):39-43. DOI: 10.1155/2001/630972.10.1155/2001/630972461882211790858Open DOISearch in Google Scholar

34. Reesink-Peters N, Helder MN, Wisman GB, et al. Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia. J Clin Pathol. 2003; 56(1):31-5. DOI:10.1136/jcp.56.1.31.10.1136/jcp.56.1.31176985512499429Open DOISearch in Google Scholar

35. Nagai N, Oshita T, Murakami J, et al. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions. Oncol Rep. 1999; 6(2):325-8. DOI:10.3892/or.6.2.325.10.3892/or.6.2.325Search in Google Scholar

36. Reddy VG, Khanna N, Jain SK, et al. Telomerase-A molecular marker for cervical cancer screening. Int J Gynecol Cancer. 2001; 11(2):100-6. DOI: 10.1046/j.1525-1438.2001.00095.x.10.1046/j.1525-1438.2001.00095.xOpen DOISearch in Google Scholar

37. Castro-Duque AF, Loango-Chamorro N, Ruiz-Hoyos BM, et al. Telomerase activity associated with progression of cervical lesions in a group of Colombian patients. Rev Bras Ginecol Obstet. 2015; 37(12):559-64. DOI: 10.1590/SO100-720320150005462.10.1590/SO100-720320150005462Open DOISearch in Google Scholar

38. Kyo S, Takakura M, Tanaka M, et al. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int J Cancer. 1998; 79(1):66-70. DOI: 10.1002/(SICI)1097-0215(19980220)79:1<66::AID-IJC13>3.0.CO;2-F.10.1002/(SICI)1097-0215(19980220)79:1<66::AID-IJC13>3.0.CO;2-Open DOISearch in Google Scholar

39. Takakura M, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 1998; 58(7):1558-61.Search in Google Scholar

40. Ault KA, Allen HK, Phillips SL, et al. Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smears. J Low Genit Tract Dis. 2005; 9(2):93. DOI: 10.1097/00128360-200504000-00005.10.1097/00128360-200504000-00005Open DOISearch in Google Scholar

41. Kailash U, Soundararajan CC, Lakshmy R, et al. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer. 2006;95(9):1250-7. DOI:10.1038/sj.bjc.6603375.10.1038/sj.bjc.6603375Open DOISearch in Google Scholar

42. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002;66(3):407-25. DOI: 10.1128/MMBR.66.3.407-425.2002.10.1128/MMBR.66.3.407-425.2002Open DOISearch in Google Scholar

43. Cao Y, Bryan TM, Reddel RR. Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci. 2008; 99(6):1092-9. DOI: 10.1111/j.1349-7006.2008.00815.x.10.1111/j.1349-7006.2008.00815.xOpen DOISearch in Google Scholar

44. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature. 1996; 380(6569):79-82. DOI:10.1038/380079a0.10.1038/380079a0Open DOISearch in Google Scholar

45. Huang PS, Patrick DR, Edwards G, et al. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol Cell Biol. 1993; 13(2):953-60. DOI: 10.1128/MCB.13.2.953.10.1128/MCB.13.2.953Open DOISearch in Google Scholar

46. Oh ST, Kyo S, Laimins LA. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J Virol. 2001; 75(12):5559-66. DOI:10.1128/JVI.75.12.5559-5566.2001.10.1128/JVI.75.12.5559-5566.200111426811356963Open DOISearch in Google Scholar

47. Cullen AP, Reid RI, Campion MI, et al. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol. 1991;65(2):606-12.10.1128/jvi.65.2.606-612.1991Search in Google Scholar

48. Doorbar J, Quint W, Banks L, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012; 30:F55-70. DOI: 10.1016/j.vaccine.2012.06.083.10.1016/j.vaccine.2012.06.08323199966Open DOISearch in Google Scholar

49. Wang SZ, Sun JH, Zhang W, et al. Telomerase activity in cervical intraepithelial neoplasia. Chin Med J (Engl). 2004; 117(2):202-6.Search in Google Scholar

50. Snijders PJ, van Duin M, Walboomers JM, et al. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res. 1998; 58(17):3812-8.Search in Google Scholar